Drugs / SeV-G(NP)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01705990 | Mar 2013 → Mar 2015 | HIV infectious disease | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SeV-G(NP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01705990 ↗ |
| Modality | Vaccine | “replication-competent Sendai virus (SeV)-vectored, human immunodeficiency virus type 1 (HIV-1) vaccine” PMID 28077588 ↗ Oct 2016 |
| Route | Intranasal | “Delivered intranasally by drops” NCT01705990 ↗ |